ChinaBio® Partnering Forum Brings Large
Scale Biotech/Pharma Partnering
to China
First Dedicated Biotech/Pharma Partnering Conference
in China Scheduled
for June 23–24, 2009 in Shanghai
Carlsbad, USA, and Shanghai, China, March 12,
2009: EBD Group, the leading partnering firm
for the global life science industry, and ChinaBio® LLC,
today announced the launch of a co-produced partnering
conference, the ChinaBio® Partnering Forum, to be held
June 23–24, 2009 in Shanghai, China. The ChinaBio® Partnering
Forum is the first biotech/pharma partnering conference
to be held in China, and promises to become the largest
and most productive such event in the country.
The China biotech market continues to develop at a rapid
pace, with great potential for providing future innovation,
novel drugs and partnering opportunities. The fundamentals
driving partnering in the biotech industry remain vibrant
worldwide despite current economic challenges. Pharmaceutical
companies continue to seek new products from the biotech
sector to fill their drug pipelines, and biotech companies
increasingly look to pharmaceutical firms for funding.
“China is becoming a priority for international life
science companies. As a current and future source of discovery
breakthroughs and medical innovations, China life science
firms and universities must be engaged,” said Carola Schropp,
President of EBD Group. “The ChinaBio Partnering Forum
is a unique event designed to facilitate partnerships
between Chinese biotechs and service providers and the
international biotech/pharma value chain.”
Greg Scott, President and Founder of ChinaBio® LLC added
“We are excited to be collaborating with EBD Group, whose
expertise in facilitating partnerships is unparalleled.
Combining EBD Group’s successful partnering platform and
their international biotech and pharma network with ChinaBio’s
deep contacts and understanding of China’s biotech and
pharma industry, will enable the ChinaBio Partnering Forum
to establish itself as the major partnering event in China.”
The addition of the ChinaBio® Partnering Forum extends
EBD Group’s family of partnering events into Asia. As
a leading partnering firm in the life sciences, EBD Group
today produces the annual international partnering events
BIO-Europe, BIO-Europe Spring®, BioPharm America™ and
EuroMedtech™. Last year’s BIO-Europe was the largest stand-alone
partnering event ever held with 2,400 delegates from 45
different countries who engaged in over 10,000 one-to-one
partnering meetings.
Partnering at the ChinaBio® Partnering Forum will be
powered by EBD Group’s partneringONE™ software. The industry’s
most advanced networking system, partneringONE enables
delegates to efficiently search a large pool of potential
partners, and pre-arrange private one-to-one meetings
with dozens of company targets.
ChinaBio® has produced a number of successful events
in China, including their ChinaBio® Investor Forums in
Shanghai, Beijing, Suzhou and Hong Kong, and the BioCapital
China Summit in Beijing. Their events have stimulated
over USD 60 million investment and partnerships with early-
and mid-stage life science companies in China.
General registration for the ChinaBio® Partnering Forum
is now open, and a discounted early bird registration
rate is available until May 15. For more information about
the ChinaBio® Partnering Forum 2009, including accommodation
and program updates, please go to the event homepage at
www.ebdgroup.com/cbpf.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has
rapidly launched a number of successful initiatives connecting
China biotech with the world. With offices in Shanghai,
Silicon Valley and San Diego, ChinaBio®’s activities include:
- Conferences: Organizer of the premier life science
investment and partnering forums in China.
- Consulting: Helping big pharma, entrepreneurs and
investors achieve success in China.
- Accelerator: Assisting early stage China companies
to raise over USD 60 million to date.
- Research: Developing in-depth research data on novel
technology development, clinical trial activity, VC
investment, M&A/IPO and partnering activity in China.
- ChinaBio® Today: Publishing online and email newsletters
focusing exclusively on China’s life science industry.
About EBD Group
EBD Group is the leading partnering firm for the global
life science industry. Since 1993, biotech, pharma and
medical device companies have leveraged EBD Group’s partnering
conferences, technology and services to identify business
opportunities and develop strategic relationships essential
to their success.
EBD Group’s conferences are run with the support of leading
corporations and international trade associations and
include:
- BIO-Europe and BIO-Europe Spring®, the world's largest
stand-alone life science partnering conferences, supported
by the Biotechnology Industry Organization (BIO)
- BioPharm America™, EBD Group’s North American partnering
event
- EuroMedtech™, EBD Group’s new partnering event for
the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized
with BioCentury Publications and BIO
EBD Group’s sophisticated web-based partnering service,
partneringONE™, is used as the partnering engine at numerous
third-party events around the world. Outside of the conference
format, EBD Group’s consultants provide hands-on assistance
for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
Contact:
In the USA
Constantine Theodoropulos
EBD Group
USA: +1 617 292 7319
ctheodoropulos@ebdgroup.com
In China
Jean Meng
ChinaBio LLC
China: +86 5137 0751
USA: +1 858 926 4566
jmeng@chinabiollc.com
